Bayer Ordered to Pay $332 Million in Roundup Cancer Case by California Jury

Jury awards $7 million in compensatory damages and $325 million in punitive damages to Carlsbad resident who claims his non-Hodgkin lymphoma was caused by the glyphosate in Bayer's Roundup weed killer.

Dennis Baker of Carlsbad, California, was awarded $332 million in damages by a California Jury after arguing that Bayer's Roundup weed killer, which contains the active ingredient glyphosate, caused his non-Hodgkin lymphoma. Dennis has been in remission for almost three years, but doctors warn the cancer is likely to return.
The jury found that Bayer failed to warn users about the risks related to Roundup, although they did not find Bayer negligent or the design of the product defective.
Bayer purchased Monsanto, the original manufacturer of Roundup, for $63 billion in 2018 and has since faced thousands of claims and lawsuits over the herbicide's links to cancer.
In 2020, Bayer declared it would pay up to $10.9 billion to settle around 125,000 filed and unprocessed claims in relation to Roundup, and it still has near 40,000 more to resolve.
This is not the first major payout in relation to Roundup; in 2018, Dewayne Johnson was awarded $289 million in damages as a jury ruled Bayer's product was the reason for his non-Hodgkin lymphoma.